{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T14:02:18Z","timestamp":1773496938093,"version":"3.50.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jhep.2014.09.031","type":"journal-article","created":{"date-parts":[[2014,10,5]],"date-time":"2014-10-05T20:11:09Z","timestamp":1412539869000},"page":"234-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3\/NS4A inhibitor-based treatment. A case report"],"prefix":"10.1016","volume":"62","author":[{"given":"Roberto","family":"Rossotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Travi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Pazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Baiguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrica","family":"Morra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Puoti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.09.031_b0005","first-page":"631a","article-title":"Hepatitis B and C are associated with Non-Hodgkin Lymphoma: cross-sectional study of the National Inpatient Sample Database","volume":"56","author":"Moehlen","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.09.031_b0010","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.09.031_b0015","doi-asserted-by":"crossref","first-page":"4262","DOI":"10.1073\/pnas.0303971101","article-title":"Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes","volume":"101","author":"Machida","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.09.031_b0020","first-page":"148","article-title":"Splenic lymphoma with circulating villous lymphocytes\/splenic marginal zone lymphoma","volume":"36","author":"Catovsky","year":"1999","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jhep.2014.09.031_b0025","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1046\/j.1365-2141.2003.04165.x","article-title":"Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients","volume":"120","author":"Parry-Jones","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jhep.2014.09.031_b0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1097\/00000478-200110000-00007","article-title":"Progression to large B cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases","volume":"25","author":"Camacho","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2014.09.031_b0035","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11864-007-0026-0","article-title":"Splenic marginal zone lymphoma with and without villous lymphocytes","volume":"8","author":"Matutes","year":"2007","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.jhep.2014.09.031_b0040","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdu166","article-title":"Antiviral treatment in patients with indolent B cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi","volume":"25","author":"Arcaini","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2014.09.031_b0045","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2014.09.031_b0050","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jhep.2014.09.031_b0055","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJMoa013376","article-title":"Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection","volume":"347","author":"Hermine","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.09.031_b0060","article-title":"Human interferon Alpha-2b: a therapeutic protein for cancer treatment","volume":"2014","author":"Asmana Ningrum","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.jhep.2014.09.031_b0065","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1365-2141.1996.d01-1711.x","article-title":"Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients","volume":"93","author":"Troussard","year":"1999","journal-title":"Br J Hematol"},{"key":"10.1016\/j.jhep.2014.09.031_b0070","doi-asserted-by":"crossref","first-page":"11434","DOI":"10.1074\/jbc.M110.211417","article-title":"Combined X-ray, NMR, and kinetic analyses reveal uncommon binding characteristics of the hepatitis C virus NS3-NS4A protease inhibitor BI 201335","volume":"286","author":"Lemke","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.09.031_b0075","doi-asserted-by":"crossref","DOI":"10.3851\/IMP2684","article-title":"Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritis","author":"De Nicola","year":"2013","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jhep.2014.09.031_b0080","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/annrheumdis-2012-202770","article-title":"Peg-IFN\/ribavirin\/protease inhibitor combination in hepatitis C virus associated mixed cryoglobulinemia vasculitis: results at week 24","volume":"73","author":"Saadoun","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814007259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814007259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T20:20:53Z","timestamp":1538166053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814007259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0168827814007259"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.09.031","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3\/NS4A inhibitor-based treatment. A case report","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.09.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}